Helicobacter pylori and risk for gastric adenocarcinoma

Seminars in Gastrointestinal Disease

Volumn 12, Issue 3, 2001, Pages 203-208

  Asghar, R J ^a   Parsonnet, J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER MORTALITY; CANCER RISK; CASE REPORT; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GASTRITIS; GENOTYPE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEREDITY; HIGH RISK POPULATION; HOST PARASITE INTERACTION; HUMAN; MALE; REVIEW; RISK FACTOR; SCREENING; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; SYMPTOM;

ADENOCARCINOMA; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0034944323     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. Cancer statistics, 2001
3. Association of Helicobacter pylori infection with gastric cancer
4. Gastric cancer and Helicobacter pylori: A combined analysis of twelve case- control studies nested within prospective cohorts
5. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
6. Helicobacter pylori infection and the risk of gastric carcinoma
7. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis
8. Differential gene expression during multistage carcinogenesis
9. Too many rodent carcinogens: Mitogenesis increases mutagenesis
10. The role of cell proliferation in multistage carcinogenesis
11. Active oxygen species as factors in multistage carcinogenesis
12. Ammonia: A possible promotor in Helicobacter pylori-related gastric carcinogenesis
13. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia
14. Influence of H pylori on gastric mucosa: Analysis of protective factors and proliferative cell kinetics
15. Helicobacter pylori and increased cell proliferation
16. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide
17. Oxidative DNA damage accumulation in gastric carcinogenesis
18. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo
19. Peroxidation and antioxidants in stomach: The role of Helicobacter pylori infection
20. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa
21. Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct
22. Helicobacter pylori infection induces gastric cancer in mongolian gerbils
23. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
24. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
25. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach
26. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
27. Epidemiology of gastric cancer: An evaluation of available evidence
28. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy
29. Schistosomes, liver flukes and Helicobacter pylori
30. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials
31. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer
32. Eradication of Helicobacter pylori improves gastric acid secretion and histology in patients with atrophic gastritis
33. Helicobacter pylori eradication and antral intestinal metaplasia - Two years follow-up study
34. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori
35. Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation
36. Changes in the gastric mucosa following eradication of Helicobacter pylori
37. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori
38. Atrophy and intestinal metaplasia one year after cure of H pylori infection: A prospective, randomized study
39. Change in worst biopsy diagnosis at 1 year after Helicobacter pylori eradication therapy
40. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy
41. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
42. Helicobacter pylori in peptic ulcer disease
43. Canadian Helicobacter pylori consensus conference
44. Recent developments in the epidemiology of Helicobacter pylori
45. A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States